These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18257613)

  • 1. Sildenafil: a review of its use in pulmonary arterial hypertension.
    Croom KF; Curran MP
    Drugs; 2008; 68(3):383-97. PubMed ID: 18257613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension.
    Durongpisitkul K; Pornrattanarungsi S; Panjasamanvong P; Chungsomprasong P
    J Med Assoc Thai; 2011 Apr; 94(4):421-6. PubMed ID: 21591526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension.
    Ramani GV; Park MH
    Drug Des Devel Ther; 2010 May; 4():61-70. PubMed ID: 20531962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil for the treatment of pulmonary hypertension in children.
    Beghetti M; Wacker Bou Puigdefabregas J; Merali S
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1157-84. PubMed ID: 25223406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
    Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
    Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension.
    Leibovitch L; Matok I; Paret G
    Drugs; 2007; 67(1):57-73. PubMed ID: 17209664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children.
    Nemoto S; Sasaki T; Ozawa H; Katsumata T; Kishi K; Okumura K; Mori Y; Umegaki O
    Eur J Cardiothorac Surg; 2010 Jul; 38(1):71-7. PubMed ID: 20206543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
    Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
    Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.
    Zeng WJ; Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Gu Q; Zhao ZH; Li JJ; He JG;
    Clin Cardiol; 2011 Aug; 34(8):513-8. PubMed ID: 21678455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of sildenafil in pulmonary artery hypertension.
    Singh TP
    Expert Rev Respir Med; 2010 Feb; 4(1):13-9. PubMed ID: 20387288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
    Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM
    BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
    Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
    Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil for pulmonary hypertension: need for evidence generation.
    Shafiq N; Reddy S; Pandhi P; Manoj R; Talwar KK; Malhotra S
    Int J Clin Pharmacol Ther; 2008 Dec; 46(12):644-51. PubMed ID: 19049698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil for pulmonary arterial hypertension: when blue turns into white.
    Antoniu SA
    Expert Opin Pharmacother; 2006 Sep; 7(13):1801-10. PubMed ID: 16925506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
    Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase III, multicenter, collaborative, open-label clinical trial of sildenafil in Japanese patients with pulmonary arterial hypertension.
    Satoh T; Saji T; Watanabe H; Ogawa S; Takehara K; Tanabe N; Yamada N; Yao A; Miyaji K; Nakanishi N; Suzuki Y; Fujiwara T; Kuriyama T
    Circ J; 2011; 75(3):677-82. PubMed ID: 21304214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.
    Abman SH; Kinsella JP; Rosenzweig EB; Krishnan U; Kulik T; Mullen M; Wessel DL; Steinhorn R; Adatia I; Hanna B; Feinstein J; Fineman J; Raj U; Humpl T;
    Am J Respir Crit Care Med; 2013 Mar; 187(6):572-5. PubMed ID: 23220921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications.
    Kumar U; Sankalp G; Sreenivas V; Kaur S; Misra D
    Rheumatol Int; 2013 Apr; 33(4):1047-52. PubMed ID: 22833239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.